Skip to Main Content

Paper Details

Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.
Gastroenterology
50
2023
/, 22-gene NGS panel, BRAF, CDKN2A, CTNNB1, ERBB2, GNAS, GNAS mutations, MEN1, MEN1/, PCs, PancreaSeq, Pancreatic Cysts, SMAD4, TERT, TP53, VHL, advanced neoplasia, malignancy, mammalian target of, mitogen-activated protein kinase, mucinous cyst, mucinous cysts, pancreatic, pancreatic cyst, pancreatic cysts, pancreatic neuroendocrine tumors, patients, rapamycin, serous, serous cystadenomas
Author NameAffiliation
Patricio M PolancoUniversity of Texas Southwestern
Jason KlapmanMoffitt Cancer Center
Jennifer B PermuthMoffitt Cancer Center
Jennifer B PermuthMoffitt Cancer Center
  • 1 - 4

Datasets

Dataset
Description
Source Link
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
OncoMineCancer microarray data by gene or cancer typeLink
Release 1.2